Results 131 to 140 of about 141,382 (330)

Screening of Dystrophin Gene Deletions in Egyptian Patients with DMD/BMD Muscular Dystrophies [PDF]

open access: hybrid, 2000
Laila K. Effat   +5 more
openalex   +1 more source

Rapid and Reversible Morphing to Enable Multifunctionality in Robots

open access: yesAdvanced Intelligent Systems, EarlyView.
This article introduces a rapid, reversible, and repeatable morphing robot through a bistable latch‐mediated, spring actuated (LaMSA) mechanism. This enables an untethered, multifunctional robot to near‐instantaneously (< 50 ms) and reversibly switch between a flying and driving configuration to navigate through different environments.
Brittan T. Wilcox   +2 more
wiley   +1 more source

THE EFFECT OF PAMIDRONATE ON BONE MINERAL DENSITY IN PRIMARY OSTEOPOROSIS IN PAKISTANI POPULATION

open access: yesPakistan Armed Forces Medical Journal, 2018
Objective: To study the protective effect of Bisphosphonates (Pamidronate) in patients of primary osteoporosis in Pakistani setup. Study Design: Quasi experimental study.
Waseem Afzal   +2 more
doaj  

HMG-CoA Reductase Inhibitors Increase BMD in Type 2 Diabetes Mellitus Patients* [PDF]

open access: bronze, 2000
Yoon‐Sok Chung   +4 more
openalex   +1 more source

Reply: Assessment of Significant Change in BMD: An Equivalent Approach [PDF]

open access: bronze, 2000
Bruno Giraudeau   +2 more
openalex   +1 more source

The Role of Serum Expression Levels of Microrna-21 on Bone Mineral Density in Hypostrogenic Postmenopausal Women with Osteoporosis: Study on Level of RANKL, OPG, TGFβ-1, Sclerostin, RANKL/OPG Ratio, and Physical Activity

open access: yesActa Medica Indonesiana, 2019
Background: MiR-21 is known to play a role in osteoclast proliferation and differentiation, but the role of serum miR-21 expression in osteoporosis remains unclear.
I Nyoman Suarjana   +7 more
doaj  

Expert Perspective: How, When, and Why to Potentially Stop Antiresorptive Drugs in Osteoporosis

open access: yesArthritis &Rheumatology, EarlyView.
Osteoporosis is a chronic disease, and antiresorptive treatments are often continued for many years. Despite their established efficacy in reducing fracture risk, the most commonly used antiresorptive treatments, bisphosphonates and denosumab, have short‐ and long‐term risks that, coupled with their benefits and other unique characteristics, influence ...
Giovanni Adami, Kenneth G. Saag
wiley   +1 more source

Bone mineral density in a cohort of transfusion-dependent β-thalassemia (TDT) patients

open access: yesZanco Journal of Medical Sciences
Background and objective: β-Thalassemia is a common inherited disease in this region. A considerable number of transfusion-dependent β-thalassemia (TDT) patients suffer bone problems.
Nigar Omar, Rawand P. Shamoon
doaj   +1 more source

Changes in biochemical markers of bone metabolism and BMD during the first year after a hip fracture [PDF]

open access: bronze, 2001
Margareta Hedström   +4 more
openalex   +1 more source

Deciphering the skeletal interoceptive circuitry to control bone homeostasis

open access: yesBMEMat, EarlyView.
This review introduces the skeletal interoceptive circuitry, covering the ascending signals from bone tissues to the brain (sensors), the central neural circuits that integrate this information and dispatch commands (CPU), and the descending pathways that regulate bone homeostasis (effectors).
Yefeng Wu   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy